252 related articles for article (PubMed ID: 8641007)
1. Processing of chimeric antisense oligonucleotides by human vascular smooth muscle cells and human atherosclerotic plaque. Implications for antisense therapy of restenosis after angioplasty.
Pickering JG; Isner JM; Ford CM; Weir L; Lazarovits A; Rocnik EF; Chow LH
Circulation; 1996 Feb; 93(4):772-80. PubMed ID: 8641007
[TBL] [Abstract][Full Text] [Related]
2. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
Zhang YR; Zhang YX; Cao W; Lan XL
J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
[TBL] [Abstract][Full Text] [Related]
3. [Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells].
Bian J; Zhang B; Chen S
Zhonghua Yi Xue Za Zhi; 1999 Jan; 79(1):10-4. PubMed ID: 11600998
[TBL] [Abstract][Full Text] [Related]
4. [Suppression of vascular smooth muscle cell proliferation by an antisense oligonucleotide against PDGF receptor].
Sugiki H
Hokkaido Igaku Zasshi; 1995 May; 70(3):485-95. PubMed ID: 7590599
[TBL] [Abstract][Full Text] [Related]
5. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
Morishita R; Gibbons GH; Ellison KE; Nakajima M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8474-8. PubMed ID: 8104336
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen.
Speir E; Epstein SE
Circulation; 1992 Aug; 86(2):538-47. PubMed ID: 1353419
[TBL] [Abstract][Full Text] [Related]
7. The uptake and distribution of phosphorothioate oligonucleotides into vascular smooth muscle cells in vitro and in rabbit arteries.
Farrell CL; Bready JV; Kaufman SA; Qian YX; Burgess TL
Antisense Res Dev; 1995; 5(3):175-83. PubMed ID: 8785473
[TBL] [Abstract][Full Text] [Related]
8. Antisense oligonucleotides to stromelysin mRNA inhibit injury-induced proliferation of arterial smooth muscle cells.
Lövdahl C; Thyberg J; Cercek B; Blomgren K; Dimayuga P; Kallin B; Hultgårdh-Nilsson A
Histol Histopathol; 1999 Oct; 14(4):1101-12. PubMed ID: 10506926
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
[TBL] [Abstract][Full Text] [Related]
10. Ex vivo antisense oligonucleotides to proliferating cell nuclear antigen and Cdc2 kinase inhibit graft coronary artery disease.
Miniati DN; Hoyt EG; Feeley BT; Poston RS; Robbins RC
Circulation; 2000 Nov; 102(19 Suppl 3):III237-42. PubMed ID: 11082394
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of c-myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells.
Shi Y; Hutchinson HG; Hall DJ; Zalewski A
Circulation; 1993 Sep; 88(3):1190-5. PubMed ID: 8353880
[TBL] [Abstract][Full Text] [Related]
12. Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.
Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ
Trans Assoc Am Physicians; 1993; 106():54-61. PubMed ID: 8036745
[No Abstract] [Full Text] [Related]
13. Antisense oligonucleotides to the p65 subunit of NF-kB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries.
Autieri MV; Yue TL; Ferstein GZ; Ohlstein E
Biochem Biophys Res Commun; 1995 Aug; 213(3):827-36. PubMed ID: 7654244
[TBL] [Abstract][Full Text] [Related]
14. The anti-proliferative effect of proliferating cell nuclear antigen-specific antisense oligonucleotides on human gastric cancer cell lines.
Sakakura C; Hagiwara A; Tsujimoto H; Ozaki K; Sakakibara T; Oyama T; Ogaki M; Takahashi T
Surg Today; 1995; 25(2):184-6. PubMed ID: 7772926
[TBL] [Abstract][Full Text] [Related]
15. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model.
Simons M; Edelman ER; Rosenberg RD
J Clin Invest; 1994 Jun; 93(6):2351-6. PubMed ID: 7911126
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin is not a marker for proliferating human vascular smooth muscle cells.
Newman CM; Bruun BC; Porter KE; Mistry PK; Shanahan CM; Weissberg PL
Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):2010-8. PubMed ID: 7583583
[TBL] [Abstract][Full Text] [Related]
17. [Effect of protein expression on antisense c-myc and PCNA for vascular smooth muscle cells].
Bian J; Zhang B; Qian H; Chen S
Zhonghua Wai Ke Za Zhi; 2000 Feb; 38(2):140-2. PubMed ID: 11832013
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo transport and delivery of phosphorothioate oligonucleotides with cationic liposomes.
Miyano-Kurosaki N; Barnor JS; Takeuchi H; Owada T; Nakashima H; Yamamoto N; Matsuzaki T; Shimada F; Takaku H
Antivir Chem Chemother; 2004 Mar; 15(2):93-100. PubMed ID: 15185727
[TBL] [Abstract][Full Text] [Related]
19. Sequence-specific antiproliferative effects of antisense and end-capping-modified antisense oligodeoxynucleotides targeted against the 5'-terminus of basic-fibroblast-growth-factor mRNA in coronary smooth muscle cells.
Schmidt A; Sindermann J; Peyman A; Uhlmann E; Will DW; Müller JG; Breithardt G; Buddecke E
Eur J Biochem; 1997 Sep; 248(2):543-9. PubMed ID: 9346314
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens.
Nakamura Y; Suzuki T; Miki Y; Tazawa C; Senzaki K; Moriya T; Saito H; Ishibashi T; Takahashi S; Yamada S; Sasano H
Mol Cell Endocrinol; 2004 Apr; 219(1-2):17-26. PubMed ID: 15149723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
